Where the first surgery matters most of all in oncology.
A sarcoma operated badly once is a problem multiplied. This is the field where imaging, biopsy planning and compartment-aware excision must come before any blade moves — because there are no easy second chances.
What are sarcomas?
Sarcomas are rare tumours of the soft tissues (muscle, fat, nerve, vessel — in limbs, trunk and retroperitoneum) or bone (osteosarcoma, Ewing's). Related entities like desmoid tumours and GIST complete this family.
Their rarity is exactly the danger: a lump shelled out casually without biopsy can seed recurrence along the scar. The first operation determines the whole trajectory.
The encouraging truth: with correct planning — imaging first, biopsy through a planned tract, wide excision — most limb sarcomas today are cured without losing the limb.
Warning signs that deserve specialist review
Most lumps are harmless lipomas — but these features separate the ones needing proper workup from those needing only reassurance.
- ①A lump growing steadily over weeks to months.
- ②Any deep lump larger than five centimetres — size plus depth is the classic red flag.
- ③A painful lump — pain raises the priority of investigation.
- ④A lump recurring after previous removal, especially if it was never biopsied.
- ⑤Limb swelling alongside a known lump.
- ⑥A lump previously removed without testing — deserves specialist re-examination even if all seems quiet now.
- ⑦Bone pain at rest or at night, or a fracture after minor injury — especially in the young.
- ⑧Any lump scheduled for removal without prior imaging or biopsy — pause and take a second opinion first.
Tumours we treat here
◆Soft-Tissue Sarcoma — Limb & Trunk
Wide compartment-aware excision planned on MRI before anything else.
◆Retroperitoneal Sarcoma
Multivisceral resections for deep abdominal tumours, planned with organ involvement mapped.
◆Bone Sarcomas
Osteosarcoma and Ewing's managed jointly with orthopaedic oncology teams.
◆Desmoid Tumours
Aggressive-but-benign growths treated with measured, often conservative-first strategies.
◆GIST
Stomach/intestinal stromal tumours — targeted therapy and surgery in the right sequence.
◆Re-excision Service
Correcting incompletely removed lumps — restoring proper margins before trouble returns.
Operations performed here
- ◆Wide compartment-aware excisionsMargins respecting anatomical boundaries — the core of durable cure.
- ◆Limb-salvage surgeryFunction-preserving resection and reconstruction instead of amputation wherever safely possible.
- ◆Retroperitoneal multivisceral resectionDeep-tumour removal involving adjacent organs when they sit in harm's way.
- ◆Re-excision of shelled-out lumpsTaking previous scars to full depth and width so residual disease meets its match.
- ◆Coordinated radiotherapy/chemotherapy pathwaysSequenced around surgery when they shrink tumours or protect margins.
- ◆GIST managementTargeted tablets and surgery combined by evidence, not habit.
From first visit to full recovery
Imaging before any cut
MRI defines the true extent — never the other way round.
Biopsy done right
Needle or incision placed along the future surgical line.
Board planning
Orthopaedic oncology, radiation and medical oncology aligned.
Wide excision
The definitive operation performed once, properly.
Reconstruction & rehab
Flap coverage and physiotherapy restore form and function together.
Surveillance
Scheduled scans watch the site closely for years ahead.
Families usually ask…
Because in sarcoma, an unplanned first operation can scatter tumour cells along the scar and turn a curable situation into a difficult one. One extra consultation before surgery costs days; correcting a whoops procedure costs months and sometimes more.
In most modern cases, no. Limb-salvage surgery with reconstruction is the standard of care for the majority of limb sarcomas, with survival equal to amputation. Amputation remains necessary occasionally — but as a considered last resort, never a default.
It means removing the tumour together with a protective cuff of healthy tissue in every direction, respecting anatomical compartments. Shaving close to cancer cells invites return; a proper margin makes recurrence far less likely.
It behaves like one and deserves respect, though its treatment is unique — targeted tablets often do what chemotherapy cannot. With the right drug-surgery sequence, long-term control is very achievable.
A returning lump after untested removal needs review — bring the old reports and scan if available. We will assess whether a planned re-excision with proper margins settles it completely. It usually does, when done right this time.